Stay updated on Pembrolizumab CNS Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab CNS Metastases Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Investigator and affiliation details were updated: Nancy Wang, M.D., Massachusetts General Hospital, with credentials added, and Priscilla Brastianos, MD, removed from the record. This reflects a change in the study's listed leadership and contact information for NCT02886585.
    Difference
    0.5%
    Check dated 2026-07-27T05:54:36.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, indicating a minor platform update. It affects the site’s revision label but does not modify the study information shown on the page.
    Difference
    0.0%
    Check dated 2026-07-05T13:35:33.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    This update adds posted results and expands the description of primary and secondary outcomes, including intracranial and extracranial endpoints and toxicity measures, with definitions and time frames. It also adds study documents (protocol and informed consent) and notes the results submission/posting dates, reflecting new data availability and end-point details.
    Difference
    3%
    Check dated 2026-06-28T08:06:39.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    New user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added and the recruitment status updated to No longer looking for participants, clarifying how to engage with the study. A formatting adjustment to the Intervention/Treatment header accompanies a version update (Revision: v3.6.0) with the older revision tag removed.
    Difference
    0.4%
    Check dated 2026-06-13T16:53:27.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The page now shows a Revision: v3.5.5 tag, replacing the previous v3.5.4 tag, indicating the current software version powering the site.
    Difference
    0.1%
    Check dated 2026-06-06T12:33:07.000Z thumbnail image
  9. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.5.4 replaces the previous v3.5.3 on the study page. This represents a minor site build update to the rendering template used for the record, with no change to the study data.
    Difference
    0.1%
    Check dated 2026-05-15T23:51:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab CNS Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.